|
Oseltamivir (Tamiflu) again proves the need for RCT
|
|
15
|
638
|
August 31, 2026
|
|
Clinicians increased awareness of RCT structure
|
|
1
|
202
|
August 8, 2026
|
|
Randomized non-comparative trials: an oxymoron?
|
|
89
|
5281
|
July 10, 2026
|
|
Cause-Agnostic RCT (CAR)
|
|
10
|
656
|
July 5, 2026
|
|
Statin-related side effects: the recent Lancet publication is biased toward false-negatives
|
|
34
|
1124
|
June 21, 2026
|
|
The Petty/Bone RCT
|
|
111
|
9159
|
June 17, 2026
|
|
Generalizability vs. Transportability in Trials
|
|
79
|
2067
|
June 11, 2026
|
|
Dichotomization
|
|
86
|
5674
|
June 10, 2026
|
|
Collider in RCT Subgroup Analysis
|
|
34
|
867
|
June 7, 2026
|
|
Relaxing Assumptions and Targeted Estimands with MOST
|
|
12
|
345
|
May 27, 2026
|
|
The growing interest in integrating causal inference and Design Theory
|
|
13
|
647
|
May 16, 2026
|
|
A/B Testing for Information Gain
|
|
1
|
87
|
April 2, 2026
|
|
One-sided significance threshold of less than 0.1 in Phase 2 clinical trial
|
|
7
|
253
|
February 25, 2026
|
|
Oh dear - wrong interpretation on a coffee study
|
|
8
|
538
|
January 14, 2026
|
|
Should causal modeling be a required part of a NIH grant applications?
|
|
1
|
137
|
December 17, 2025
|
|
Critique of paper on generalizability of oncology trials
|
|
27
|
2655
|
December 10, 2025
|
|
The Design Theory /Causal Inference Divide Explained by the Position of U
|
|
2
|
206
|
November 28, 2025
|
|
Omission of *absolute* risk reduction from NEJM Editorial on PSA testing
|
|
14
|
566
|
November 27, 2025
|
|
Decades of underpowered RCT
|
|
24
|
783
|
November 20, 2025
|
|
Individual response
|
|
266
|
50178
|
November 17, 2025
|
|
Feedback on BayeScores: A Bayesian AFT Mixture Cure Model for Quantifying Clinical Benefit
|
|
3
|
214
|
November 11, 2025
|
|
What is a fake measurement tool and how are they used in RCT
|
|
54
|
21044
|
November 4, 2025
|
|
When and why (not) to worry about the PO assumption
|
|
4
|
805
|
October 9, 2025
|
|
Comparing multiple groups to a reference group
|
|
7
|
292
|
October 6, 2025
|
|
Bayesian Clinical Trials: Interview with Frank Harrell
|
|
0
|
264
|
September 18, 2025
|
|
Should cSM be part of CONSORT
|
|
1
|
153
|
September 12, 2025
|
|
Sample Size Calculation for a 2x2 Factorial RCT
|
|
6
|
557
|
September 3, 2025
|
|
Causal inferences from RCTs- could “toy” clinical examples promote understanding?
|
|
17
|
2485
|
August 4, 2025
|
|
Why the Non-Reproducibility of Acute Care RCT? The CAP studies
|
|
6
|
277
|
May 8, 2025
|
|
Use of conditional estimands in regulatory settings
|
|
2
|
213
|
April 29, 2025
|